Upsher-Smith Laboratories launches Fluoxetine Oral Solution, USP, 20mg/5mL
27 January 2023 -

Upsher-Smith Laboratories, LLC (Upsher-Smith), a United States-based pharmaceutical company, announced on Thursday that it has expanded its fluoxetine product range with the introduction of Fluoxetine Oral Solution, USP, 20mg/5mL.

The product is a generic version of Prozac (fluoxetine) Oral Solution.

Rich Fisher, Upsher-Smith president and COO, said, 'We are very excited to lead this calendar year off with the launch of Fluoxetine Oral Solution. Upsher-Smith has many exciting things in store for 2023 including the opening of our world-class manufacturing facility in Maple Grove, MN, and a rich pipeline of high-quality generic products, positioning the Company for both near-term and future growth.'